|
| INDEX |
|
| INTRODUCTION |
| overview || chapter summary || website
|| RenDER || USRDS database || administrative oversight
|| reading the maps |
|
Download:
Windows 
Mac |
| |
| PRÉCIS (p17
- 32) |
| ESRD counts & spending || trends
in modalities || quality of care || hospitalization & mortality
|| ESRD expenditures || CKD populations & expenditures |
|
Download:
Windows
Mac |
| |
| HEALTHY
PEOPLE 2010 (p33
- 46) |
| incident rates || cardiovascular disease
|| fistula use || vaccinations || transplantation ||
diabetes || pre-ESRD diabetic care || achievement of
HP2010 objectives, by network |
|
Download:
Windows
Mac |
| |
| CHAPTER
ONE · CHRONIC KIDNEY DISEASE (p47
- 64) |
| prevalence || assessment of at-risk populations
|| preventive healthcare monitoring || hospitalization
|| acute kidney failure || adherence to prescription
drug therapy |
|
Download:
Windows
Mac |
| |
| CHAPTER
TWO · INCIDENCE & PREVALENCE OF ESRD (p65
- 80) |
|
incidence || racial differences in the incidence
of ESRD || prevalence || incidence & prevalence,
by primary diagnosis || rare diseases || geriatric
nephrology || ESRD network populations |
|
Download:
Windows
Mac |
| |
| CHAPTER
THREE · PATIENT CHARACTERISTICS (p81
- 94) |
|
cardiovascular comorbidity || adherence to prescription
drug therapy || EPO use & anemia at initiation
|| biochemical characteristics & BMI || predictors
of eGFR |
|
Download:
Windows
Mac |
| |
| CHAPTER
FOUR · TREATMENT MODALITIES (p95
- 106) |
|
incident modality || prevalent modality
|| modality & changes over treatment time || modality & provider
characteristics |
|
Download:
Windows
Mac |
| |
| CHAPTER
FIVE · CLINICAL INDICATORS & PREVENTIVE
CARE (p107 - 120) |
| vascular access || diabetic care || adherence
to prescription drug therapy in dialysis patients ||
anemia treatment || anemia management || EPO resistance
|| preventive care |
|
Download:
Windows
Mac |
| |
| CHAPTER
SIX · MORBIDITY & MORTALITY (p121
- 144) |
|
overall hospitalization || cause-specific hospitalization
|| overall mortality || cause-specific mortality
|| stroke || peripheral neuropathy || dementia |
|
Download:
Windows
Mac |
| |
| CHAPTER
SEVEN · TRANSPLANTATION (p145
- 158) |
|
wait list || transplant & donation rates || graft
survival || immunosuppression || post-transplant
complications || listings & use of ECD kidneys
|| projected wait times |
|
Download:
Windows
Mac |
| |
| CHAPTER
EIGHT · PEDIATRIC ESRD (p159
- 172) |
| patient characteristics
|| preventive health || vascular access || modality
|| anemia treatment
|| infectious complications || all-cause & cause-specific
hospitalization & mortality |
|
Download:
Windows
Mac |
| |
| CHAPTER
NINE · CARDIOVASCULAR SPECIAL STUDIES (p173
- 184) |
|
demographics & comorbidity || AMI in incident & prevalent
patients || CHF in incident & prevalent patients
|| cardiac arrest in incident & prevalent patients
|| cardiovascular event rates in HD & PD patients
|| implantable cardioverter defibrillators || cardiovascular
procedure use in dialysis patients |
|
Download:
Windows
Mac |
| |
| CHAPTER
TEN · ESRD PROVIDERS (p185
- 198) |
| provider growth
|| patient characteristics, by unit affiliation ||
provider compliance with K/DOQI & preventive
care guidelines || provider differences in preventive
care || provider differences in Bayesian mortality & hospitalization
ratios |
|
Download:
Windows
Mac |
|
|
| |
| CHAPTER
ELEVEN · ECONOMIC
COSTS OF ESRD (p199
- 214) |
| overall costs of
CKD & ESRD || components
of costs || ESRD program expenditures || per person
per year expenditures, by modality || components of
care || vascular access expenditures || Medicare Advantage
(Part C) patients |
|
Download:
Windows
Mac |
|
|
| |
| CHAPTER
TWELVE · INTERNATIONAL
COMPARISONS (p215
- 226) |
|
incidence || prevalence || dialysis || transplantation |
|
Download:
Windows
Mac |
|
|
| |
| APPENDICES |
|
|
Download:
Windows
Mac |
|
|
| |
| |
